Skip to main content
Caplight Logo









Embio Diagnostics

Embio Diagnostics

Private
NicosiaHealthcare & Life Scienceshttps://embiodiagnostics.eu/

Last Round

Grant

Jun 4, 2026

Total Funding Raised

$3.88M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Embio Diagnostics is a biotechnology company that designs and develops portable, biosensor-based, and digital devices for rapid diagnostics in food safety, air quality, and environmental research.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Environmental Monitoring, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

biosensorelectrochemical analyzerportable diagnostic devicelab-on-a-chipfood safety testingair quality monitoringon-site testingpathogen detectionenvironmental monitoringrapid diagnosticspoint-of-care testingPOCTbiotech hardwareAI-enhanced diagnosticsindustrial sensor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Embio Diagnostics Comparables

Compare Embio Diagnostics with similar companies based on industry and business-model similarity.

Embio Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioEclosion
75%
LuminUltra
71%
EW Group
68%

Embio Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 4, 2026
GrantMar 2, 2026
SeedNov 15, 2024
SeedDec 13, 2021

Key People

Founding team and executive leadership

Constantinos Loizou

CEO

Executive Team

Antonios Inglezakis

Chief Technology Officer, Embedded Systems Engineer - Chief Engineer, Head Of Electronics and Hardware Department

Executive Team

Savvas Achilleos

Chief Financial Officer

Executive Team

Lina Kourtella

Chief Operating Officer

Executive Team

Embio Diagnostics Investors

Notable investors and investment history

Embio Diagnostics investors
InvestorRounds
European Innovation CouncilGrant
Kinisis VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2026

    Received funding from the European Innovation Council.

  • Apr 19, 2026

    Grew 15% QoQ from 26 to 30 employees.

Embio Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Embio Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Embio Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNicosia
Employee Range24
Year Founded2016
Last FundingJun 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?